Clinical trial
A Study on the Efficacy of Thyroid Hormone Replacement Therapy for Secondary Hypothyroidism Following Intracerebral Hemorrhage
NCT06353555 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study on the Efficacy of Thyroid Hormone Replacement Therapy for Secondary Hypothyroidism Following Intracerebral Hemorrhage
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 11, 2023
- Completion date
- December 31, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hormone replacement therapy, intracerebral hemorrhage, low t3 syndrome, neurocritical care